Rare Cancer Syndromes: The Li-Fraumeni Syndrome Market and Genetic...

a adăugat un sunet Health

2026-07-30 08:51:32 - Translate -

Rare Cancer Syndromes: The Li-Fraumeni Syndrome Market and Genetic Testing Innovations

Rare cancer syndromes represent a significant challenge in oncology, requiring accurate diagnosis and comprehensive management approaches. Li-Fraumeni syndrome, a rare cancer syndrome caused by TP53 mutations, exemplifies the importance of effective rare cancer syndromes management. The treatment market is experiencing steady growth, with projections from USD 0.87 billion in 2025 to...

0 Commentarii 0 Distribuiri 88 Views 0 previzualizare